Invention Grant
- Patent Title: Compositions comprising an anti-metallothionein antibody and a pancreatic cell targeting moiety
-
Application No.: US16961327Application Date: 2019-01-17
-
Publication No.: US11866488B2Publication Date: 2024-01-09
- Inventor: Michael A. Lynes , Yu-Hua Tseng , Matthew D. Lynes
- Applicant: UNIVERSITY OF CONNECTICUT , JOSLIN DIABETES CENTER, INC.
- Applicant Address: US CT Farmington
- Assignee: UNIVERSITY OF CONNECTICUT,JOSLIN DIABETES CENTER, INC.
- Current Assignee: UNIVERSITY OF CONNECTICUT,JOSLIN DIABETES CENTER, INC.
- Current Assignee Address: US CT Farmington; US MA Boston
- Agency: MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP
- International Application: PCT/US2019/013934 2019.01.17
- International Announcement: WO2019/143767A 2019.07.25
- Date entered country: 2020-07-10
- Main IPC: C07K16/40
- IPC: C07K16/40 ; C07K16/18 ; A61P3/10 ; A61K45/06 ; A61K39/00
Abstract:
Disclosed herein are compositions including an inhibitor of extracellular human metallothionein (MT) and a pancreatic targeting moiety linked to the inhibitor of extracellular human MT.
Public/Granted literature
- US20200369757A1 METHODS FOR TREATING DIABETES, HEPATITIS, AND/OR INFLAMMATORY LIVER DISEASE Public/Granted day:2020-11-26
Information query
